Retatrutide 20mg: extended-protocol research vial
The 20mg presentation doubles the peptide payload per vial without changing any aspect of synthesis, purity standard or third-party verification. It is the recommended option for research groups conducting multi-week receptor pharmacology studies, dose–response titration series, or extended adipocyte and hepatocyte assays where consolidating lot handling reduces analytical noise and cost per data point.

